7 Min Read
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s)
Sept 5 (Reuters) - Some U.S. stocks to watch on Thursday:
U.S. stock index futures were little changed Thursday, as investors were reluctant to make big bets following steep gains in the previous session, and ahead of data that could provide a clue on the timing of changes to monetary policy.
S&P 500 futures rose 0.4 point. Dow Jones industrial average futures rose 6 points and Nasdaq 100 futures NDc1 rose 3.25 points.
** BAZAARVOICE INC, Wednesday close $11.23, down 10 pct after market
The consumer review aggregator forecast second-quarter revenue largely below Wall Street estimates after posting first-quarter revenue that was marginally ahead of expectations.
** CONN'S INC, Wednesday close $68.31, down 12 pct premarket
The specialty retailer of items such as home appliances and consumer electronics reported second-quarter profit that missed analysts' estimates.
** BLACKBERRY LTD, Wednesday close $10.76, up 2.3 pct premarket
The smartphone maker, which put itself up for sale in August, hopes to run a "fast" auction process that could result in the sale of the company by November, The Wall Street Journal reported on Wednesday.
Earlier on Wednesday, China's Huawei said it will not buy another mobile phone maker such as BlackBerry to increase its market share in mobile phones.
** LOUISIANA-PACIFIC CORP, Wednesday close $15.26, up 5 pct premarket
The building products maker said it would buy Canadian peer Ainsworth Lumber Co Ltd for about $1.1 billion, including debt, to expand in Asia and other international markets.
** GREIF INC, Wednesday close $55.89, down 5 pct after market
The packaging products maker reported third-quarter revenue below analysts' estimates and said it expects its rigid industrial packaging business to remain weak.
** ENVIVIO INC, Wednesday close $2.80, up 28.6 pct
The video delivery company reported second-quarter results above expectations, driven by large orders from two tier 1 North American cable customers, one of which was a new customer.
The company got 30.2 percent of its revenue in the quarter from the new tier 1 U.S. cable customer.
** QUALCOMM INC, Wednesday close $67.28
Samsung Electronics Co Ltd and Qualcomm unveiled smartwatches on Wednesday, tapping a potential "wearables" market worth an estimated $50 billion as the high-end mobile phone market becomes saturated. The companies launched the devices at nearly simultaneous events in Berlin and San Diego, and some analysts immediately questioned whether the devices were too costly, with expected prices near $300.
** GLAXOSMITHKLINE, $51.05, down 2 pct premarket
An experimental cancer vaccine from GlaxoSmithKline failed to help melanoma patients in a closely watched late-stage clinical trial, dealing a blow to the high-risk, high-reward project. Britain's biggest drugmaker said on Thursday that it would continue with the Phase III trial of its MAGE-A3 therapeutic vaccine to see if it benefited a subset of patients with a particular genetic signature.
** KAYDON CORPORATION, Wednesday close $28.90
Sweden's SKF, the world's biggest bearings maker, said on Thursday it had agreed to buy U.S.-based Kaydon Corporation in an all-cash $1.25 billion deal. SKF, which competes with U.S. group Timken TKR.N and Germany's Schaeffler AG, said the deal included $95 million of net debt and would be paid with cash on hand, boosting the group's earnings in the first year after the transaction.
** SMITHFIELD FOODS INC, Wednesday close $33.83
The U.S. government is unlikely to block Chinese meat company Shuanghui International's $4.7 billion deal to buy Smithfield Foods on national security grounds, one person familiar with the matter told Reuters.
** ASTEX PHARMACEUTICALS INC, Wednesday close $8.27, up 2 pct aftermarket
Japanese drugmaker Otsuka Holdings Co said on Thursday that it had agreed to buy Astex Pharmaceuticals for close to $900 million to tap cancer drugs under development by the U.S. company.
** AT&T, $33.72, up 1 pct aftermarket
Egyptian tycoon Naguib Sawiris, AT&T and America Movil have approached the core Telecom Italia investors who want to exit their unprofitable investment in the Italian group, a source familiar with the situation said. Contact is at a preliminary stage and the three players had not formally expressed an interest, the source added.
** BOEING, Wednesday close $106.37
The airplane maker said it expects China to need more than 5,500 aircraft in the next 20 years, a six percent increase over last year's two-decade estimate, citing growing demand for single-aisle and small wide body planes as travel within Asia-Pacifc surges.
** LOCKHEED MARTIN CORP, Wednesday close $123.63
The Pentagon's chief arms buyer on Wednesday said he did not expect the U.S. Navy to significantly change its plans to buy F-35 fighter jets built by Lockheed Martin Corp, despite mounting pressure on the U.S. military budget.
** MICROSOFT CORP, Wednesday close $31.195
The software giant said on Wednesday a jury decided in its favor in the second of two trials in federal court in Seattle concerning Motorola Mobility's licensing of so-called standard, essential patents used in Microsoft products.
** LINKEDIN CORP, Wednesday close $246.13
The professinal social network on Wednesday said it was pricing its follow-on offering of 5.4 million class A shares at $233.00 per share. The company intends to raise $1.2 billion through the offering.
** CHESAPEAKE ENERGY CORP, Wednesday close $26.16
The energy company will finalize an agreement next week to drop about 12,000 acres of land leased for energy drilling in New York state, as a moratorium on fracking continues into its sixth year.
** POZEN INC, Wednesday close $5.29, up 15 pct after market
** SANOFI US, Wednesday close $47.94
Under an agreement worth up to $35 million, the U.S. drugmaker granted France-based Sanofi a license to exclusively market two tablets it is developing to prevent cardiovascular disease in patients at risk for aspirin-associated gastric ulcers. A marketing application for the drug was accepted for approval by U.S. health regulators in May 2013, Pozen said late Wednesday.
** CHELSEA THERAPEUTICS INC, Wednesday close $3.09, up 7 pct aftermarket
The U.S. Food and Drug Administration acknowledged receipt of Chelsea's marketing application for its hypotension drug Northera and scheduled Feb. 14, 2014, as the review date for the product, the drugmaker said on Wednesday.
** WARNER CHILCOTT PLC, Wednesday close $22.09
** MYLAN INC, Wednesday close $35.93
Warner Chilcott and Australia-based Mayne Pharma Group Ltd resolved Mylan's damages claim in connection with a patent infringement suit over Warner's acne drug Doryx . Mylan will receive $12 million to satisfy the damage claims under a bond, Warner Chilcott said in a regulatory filing on Wednesday. (Compiled by Varun Aggarwal)